Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Other Operating Expenses (2017 - 2025)

ProQR Therapeutics' Other Operating Expenses history spans 5 years, with the latest figure at $0.0 for Q1 2025.

  • On a quarterly basis, Other Operating Expenses changed N/A to $0.0 in Q1 2025 year-over-year; TTM through Dec 2025 was $0.0, a 111.11% increase, with the full-year FY2025 number at -$3.1 million, down 6.64% from a year prior.
  • Other Operating Expenses hit $0.0 in Q1 2025 for ProQR Therapeutics, up from -$0.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for PRQR hit a ceiling of $0.0 in Q4 2023 and a floor of -$0.0 in Q4 2024.
  • Historically, Other Operating Expenses has averaged $0.0 across 5 years, with a median of $0.0 in 2021.
  • Biggest five-year swings in Other Operating Expenses: plummeted 300.0% in 2022 and later tumbled 200.0% in 2024.
  • Tracing PRQR's Other Operating Expenses over 5 years: stood at $0.0 in 2021, then skyrocketed by 100.0% to $0.0 in 2022, then soared by 300.0% to $0.0 in 2023, then tumbled by 200.0% to -$0.0 in 2024, then surged by 112.5% to $0.0 in 2025.
  • Business Quant data shows Other Operating Expenses for PRQR at $0.0 in Q1 2025, -$0.0 in Q4 2024, and -$0.0 in Q3 2024.